Skip to main content
METABIOMED.CO.,LTD logo

METABIOMED.CO.,LTD — Investor Relations & Filings

Ticker · 059210 ISIN · KR7059210005 KO Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2025-10-22 Regulatory Filings
Country KR South Korea
Listing KO 059210

About METABIOMED.CO.,LTD

https://www.meta-biomed.com/

METABIOMED.CO.,LTD. is a developer and manufacturer of medical devices and biomaterials. The company's operations are organized into four primary business areas: Dental, Suture Material & Biomaterial, Meta Surgical, and Cosmetic Medical. Its dental division provides a range of equipment and materials, with its root canal filling product holding the largest global market share. The company also manufactures various synthetic absorbable surgical sutures, including Poliglecaprone (PGCL) and Polydioxanone (PDO) types. The surgical division offers devices for use in general surgery, orthopedics, neurosurgery, and obstetrics & gynecology. In the cosmetic medical field, it produces products such as PDO threads. METABIOMED distributes its products to over 100 countries through a global sales network.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약해지결정)
Regulatory Filings Classification · 95% confidence The document is titled '주요사항보고서(자기주식취득 신탁계약 해지 결정)' which translates to 'Material Event Report (Termination of Treasury Stock Acquisition Trust Contract)'. It is addressed to the Financial Services Commission and Korea Exchange, indicating a regulatory filing. The content details the termination of a trust contract related to treasury stock acquisition, including contract amounts, dates, and stock quantities. The document length is 2516 characters, which is relatively short and focused on a specific event rather than comprehensive financial data or reports. This type of filing corresponds to a material event or significant transaction announcement rather than a full financial report or earnings release. According to the filing definitions, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. Therefore, the classification is RNS with high confidence.
2025-10-22 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 95% confidence The document is titled '주요사항보고서(자기주식취득 신탁계약 해지 결정)' which translates to 'Major Event Report (Termination of Treasury Stock Acquisition Trust Contract)'. It details the termination of a trust contract related to the company's own stock acquisition, including specifics about the contract amount, termination date, and stock holdings before and after termination. The document is a regulatory disclosure about a significant transaction involving the company's own shares, specifically the termination of a trust contract for treasury stock acquisition. This fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares or related transactions. The document length is 2522 characters, which is relatively short but contains substantive details about the transaction itself, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2025-10-22 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 95% confidence The document is titled '주요사항보고서(자기주식취득 신탁계약 해지 결정)' which translates to 'Major Event Report (Termination of Treasury Stock Acquisition Trust Contract)'. It details the decision to terminate a trust contract related to the acquisition of treasury shares, including specifics about the contract amount, dates, and the handling of shares and cash upon termination. The document is a regulatory disclosure about a significant corporate event involving treasury shares, not a financial report or earnings release. It is a typical form of a Major Shareholding Notification or a transaction related to own shares. Given the content focuses on the termination of a treasury stock acquisition trust contract and the handling of own shares, the most appropriate classification is Transaction in Own Shares (POS). The document length is 2519 characters, which is short and focused on a specific transaction, supporting this classification.
2025-10-22 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details the shareholding changes of a significant shareholder, including the number of shares held, changes in holdings, and related information. The document references specific dates and legal provisions related to large shareholding disclosures. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a notification of changes in significant share ownership levels, which matches the definition of 'Major Shareholding Notification'. The document length is over 6000 characters and contains detailed shareholding data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is 'MRQ' (Major Shareholding Notification).
2025-10-10 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Meta Biomed' covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business operations, shareholding structure, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report (RPA) as it contains the full content of the report itself. H1 2025
2025-08-14 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This involves the company's own shares and falls under the category of share repurchase or treasury share management. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct classification for reports regarding the company buying back or selling its own shares.
2025-08-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.